Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Pancreatic Cancers”

417 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 417 results

Testing effectiveness (Phase 2)WithdrawnNCT00882765
What this trial is testing

Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

Who this might be right for
Pancreatic Cancer
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT02308722
What this trial is testing

SBRT Pre-operatively for Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
University of Oxford 12
Testing effectiveness (Phase 2)Looking for participantsNCT06538857
What this trial is testing

CEB-01 in Locally Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Carcinoma
CEBIOTEX 39
Large-scale testing (Phase 3)Study completedNCT02172976
What this trial is testing

Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma

Who this might be right for
Resectable Prancreas Carcinoma
Krankenhaus Nordwest 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06094140
What this trial is testing

NEO-adjuvant Chemo-immunotherapy in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Australasian Gastro-Intestinal Trials Group 20
Large-scale testing (Phase 3)Study completedNCT03984214
What this trial is testing

Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectableChemotherapy-induced Nausea and VomitingPancreatic Cancer Metastatic
Arbeitsgemeinschaft medikamentoese Tumortherapie 109
Not applicableLooking for participantsNCT06595160
What this trial is testing

Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal AdenocarcinomaStage I Pancreatic Cancer AJCC v8
Emory University 87
Early research (Phase 1)Active Not RecruitingNCT02495896
What this trial is testing

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastatic Pancreatic AdenocarcinomaNon-Resectable Cholangiocarcinoma+13 more
University of Southern California 61
Testing effectiveness (Phase 2)Study completedNCT03146962
What this trial is testing

High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies

Who this might be right for
Colorectal CancerPancreatic CancerLung Cancer
Weill Medical College of Cornell University 61
Testing effectiveness (Phase 2)Looking for participantsNCT05841420
What this trial is testing

Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients with Non-resectable Pancreatic Cancer

Who this might be right for
Pancreas CancerNon-Resectable Pancreas Carcinoma
Morten Ladekarl 98
Very early researchStudy completedNCT01992705
What this trial is testing

Borderline Pancreas Study: FOLFIRINOX +SBRT

Who this might be right for
Resectable Pancreatic Cancer
University of Maryland, Baltimore 8
Not applicableUnknownNCT05489458
What this trial is testing

Predictive Factors for Resection and Survival in Type A Borderline Resectable Pancreatic Ductal Adenocarcinoma Patients After Neoadjuvant Therapy

Who this might be right for
Carcinoma, Pancreatic Ductal
BUSQUETS, JULI 100
Early research (Phase 1)Study completedNCT01918644
What this trial is testing

Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer

Who this might be right for
Stage IA Pancreatic CancerStage IB Pancreatic CancerStage IIA Pancreatic Cancer+1 more
University of Wisconsin, Madison 21
Testing effectiveness (Phase 2)Ended earlyNCT01760252
What this trial is testing

Neoadjuvant CAPOXIRI Chemotherapy in the Treatment of Pancreatic Adenocarcinoma Protocol

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Beth Israel Medical Center 17
Testing effectiveness (Phase 2)UnknownNCT01591733
What this trial is testing

FOLFIRINOX + RT for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Massachusetts General Hospital 48
Testing effectiveness (Phase 2)Study completedNCT02243358
What this trial is testing

Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreas Neoplasm Malignant Resectable
Henry Ford Health System 24
Testing effectiveness (Phase 2)WithdrawnNCT03908333
What this trial is testing

High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CancerPancreatic CancerPancreas Cancer+3 more
Medical College of Wisconsin
Testing effectiveness (Phase 2)Study completedNCT01560949
What this trial is testing

Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 34
Not applicableUnknownNCT06214533
What this trial is testing

Celiac plExus Block to Reduce OpioID Consumption Following Hepato-pancreato-biliary Mini-invasive Surgery

Who this might be right for
Pancreatic Ductal AdenocarcinomaLiver, Cancer of, Primary Resectable
Sixth Affiliated Hospital, Sun Yat-sen University 60
Not applicableLooking for participantsNCT06246630
What this trial is testing

In Vitro Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine Tumor

Who this might be right for
Advanced Pancreatic Neuroendocrine Tumor
Ruijin Hospital 20
Load More Results